A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.

Background Delirium is a common disorder in the early phase of stroke. Given the presumed cholinergic deficiency in delirium, we tested treatment with the acetylcholinesterase inhibitor rivastigmine.